Sort
64,565 grants matching “drug discovery”
Targeting neuroinflammation in AD with novel CX3CR1 agonists
$562,501Steven H Olson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AG
Informatics and Machine Learning Modules for Research Planning, Scheduling, Simulation, and Optimization in the ASPIRE Autonomous Laboratory
$562,489Connor Wilson Coley · Massachusetts Institute Of Technology · U18 · FY2022 · TR
Mali International Center for Excellence in Research: Malaria and Vectors
$562,475Robert Gwadz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Design, Syntheses and Studies of Novel Antituberculosis Agents
$562,443Marvin J Miller · University Of Notre Dame · R37 · FY2023 · AI
Pharmacological Validation of Vascular KATP Channels for Modulating Ductus Arteriosus Tone
$562,249Jerod S Denton · Vanderbilt University Medical Center · R01 · FY2021 · HD
INSECT GLUTAMATE RECEPTORS AS NOVEL INSECTICIDE TARGETS
$562,246Scott W Chouinard · Cambria Biosciences, Llc · U01 · FY2006 · AI
Genetic mechanisms of metformin's pro-longevity and anti-cancer effects
$562,208Alexander A Soukas · Massachusetts General Hospital · R01 · FY2019 · AG
Propargyl-linked Antifolates Targeting Klebsiella pneumoniae
$562,189Amy C. Anderson · University Of Connecticut Storrs · R01 · FY2014 · AI
Biocomputation across distributed private datasets to enhance drug discovery
$562,173Sean Ekins · Collaborative Drug Discovery, Inc. · R44 · FY2014 · TR
Design, Syntheses and Studies of Novel Antituberculosis Agents
$562,125Marvin J Miller · University Of Notre Dame · R37 · FY2024 · AI
Design, Syntheses and Studies of Novel Antituberculosis Agents
$562,117Marvin J Miller · University Of Notre Dame · R37 · FY2025 · AI
Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart
$562,065Sudha K Shenoy · Duke University · R01 · FY2022 · HL
Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart
$562,065Sudha K Shenoy · Duke University · R01 · FY2023 · HL
Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart
$562,065Sudha K Shenoy · Duke University · R01 · FY2021 · HL
Optimizing novel cyanide countermeasures
$562,059Randall T Peterson · Brigham And Women'S Hospital · U54 · FY2013 · NS
Discovery of Chemical Probes for Psychiatric Disorders and Addiction
$562,032Fernanda Laezza · University Of Texas Med Br Galveston · R01 · FY2018 · MH
Tumor-targeted inhibitors of stearoyl-CoA desaturase for the treatment of cancer.
$562,022Deepak Nijhawan · Ut Southwestern Medical Center · R01 · FY2021 · CA
Tumor-targeted inhibitors of stearoyl-CoA desaturase for the treatment of cancer.
$562,022Deepak Nijhawan · Ut Southwestern Medical Center · R01 · FY2020 · CA
Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases
$562,011Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2017 · AG
Multiomic profiling of cell types mediating opioid use disorder in rats
$561,976Francesca Telese · University Of California, San Diego · R01 · FY2024 · DA
Clonal Reconstruction and Targeting of the Correa Sequence
$561,961Frank D. McKeon · University Of Houston · R01 · FY2020 · CA
Graduate Training in Cellular and Molecular Pharmacology
$561,936Joan Heller Brown · University Of California, San Diego · T32 · FY2010 · GM
High-Resolution ROMA Analysis of Genome Copy Number Variation in the HapMap
$561,860Jonathan Sebat · University Of California, San Diego · P41 · FY2009 · HG
Statistical Methods For Genetic Epidemiology
$561,846Clarice Weinberg · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
Bottom-up, high-throughput prototyping of extracellular vesicle mimetics using cell-free synthetic biology
$561,799Cheemeng Tan · University Of California At Davis · R01 · FY2024 · EB